Skip to content
10-Q

Quarterly Report

Regenerative Medical Technology Group Inc. RMTG

0001213900-25-045967

← back to feed
Filed
May 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 20, 2025 12.54M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $1.22M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $1.17M
Current Liabilities Q1 2025 · Mar 31, 2025 $29.88M
Current Liabilities Q1 2025 · Dec 31, 2024 $28.97M
Total Liabilities Q1 2025 · Mar 31, 2025 $32.1M
Total Liabilities Q1 2025 · Dec 31, 2024 $31.18M
Current Assets Q1 2025 · Mar 31, 2025 $1.45M
Current Assets Q1 2025 · Dec 31, 2024 $1.25M
Total Assets Q1 2025 · Mar 31, 2025 $3.98M
Total Assets Q1 2025 · Dec 31, 2024 $3.82M
Shares Diluted Q1 2025 · Mar 31, 2024 12.49M sh
Capex Q1 2025 · Mar 31, 2024 $59.15K
Operating Cash Flow Q1 2025 · Mar 31, 2024 $107.97K
Stockholders Equity Q1 2025 · Mar 31, 2024 −$23.76M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$21.8M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.16
Eps Basic Q1 2025 · Mar 31, 2024 −$0.16
Net Income Q1 2025 · Mar 31, 2024 −$1.96M
Operating Income Q1 2025 · Mar 31, 2024 −$105.11K
Gross Profit Q1 2025 · Mar 31, 2024 $568.99K
Cost Of Revenue Q1 2025 · Mar 31, 2024 $248.04K
Revenue Q1 2025 · Mar 31, 2024 $817.03K